CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib
Status:
Enrolling by invitation
Trial end date:
2024-01-02
Target enrollment:
Participant gender:
Summary
This protocol is designed to provide patients currently benefiting from rucaparib treatment
in a Clovis-sponsored clinical study with continued access to treatment for as long as they
continue to benefit. Patients in long-term follow-up (LTFU) in a parent study may also enroll
in this study for continued data collection, as applicable based on parent study objectives.